Mirae Asset Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8459 Cr | ₹2821 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹99 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 02 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 15% |
| Expense Ratio | 1.82 | 1.92 |
| Manager | Sailesh Raj Bhan | Vrijesh Kasera |
| ISIN Code | INF204K01968 | INF769K01EA2 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | -1.57% | -1.52% |
| 6 Month | -0.56% | 0.92% |
| 1 Year | 0.39% | 1.14% |
| 3 Year | 21.28% | 20.95% |
| 5 Year | 15.77% | 15.79% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | -0.82% | -1.69% |
| 1 Year | 4.97% | 4.52% |
| 3 Year | 16.4% | 17.13% |
| 5 Year | 16.13% | 15.99% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 16.7% | 19.37% |
| 3 Year | 20.91% | 20.37% |
| 5 Year | 20.41% | 23.23% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 14.36% | 16.44% |
| Sharp | 0.98% | 0.83% |
| Beta | 0.87% | 1.00% |
| Alpha | 1.45% | -2.24% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Vrijesh Kasera |
| Total AUM | ₹96086 Cr | ₹12061 Cr |
| Funds Managed | 5 | 4 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 1.24 | 5.99 |
| Large Cap | 32.65 | 33.05 |
| Mid Cap | 35.11 | 35.7 |
| Small Cap | 31 | 25.27 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 0.34 | 0.69 |
| Healthcare | 99.66 | 98.02 |
| Basic Materials | - | 1.29 |
Top Comparisons
Motilal Oswal Large Cap Fund - Regular (G)
3Y Returns0%
Canara Robeco Large Cap Fund - Regular Plan - Growth Option
3Y Returns14.82%
ICICI Prudential Quant Fund Growth
3Y Returns16.4%
Kotak Pioneer Fund- Regular Plan- Growth Option
3Y Returns22.03%
HDFC Corporate Bond Fund - Growth Option
3Y Returns7.63%
Mirae Asset Corporate Bond Fund Regular Growth
3Y Returns7.12%
Nippon India Equity Savings Fund- Growth Plan- Bonus Option
3Y Returns%
Mirae Asset Equity Savings Fund- Regular Plan- Growth
3Y Returns10.9%